ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements [Yahoo! Finance]
ImmunoPrecise Antibodies Ltd. (IPA)
Company Research
Source: Yahoo! Finance
biotherapeutics company, announced today that the Company received written notification (the " Notification Letter ") from the Nasdaq Global Market LLC (" Nasdaq ") on August 19, 2024, indicating that the Company is not in compliance with the minimum bid price requirement set forth in the Nasdaq Rule 5450(a)(1) based on the closing bid price of the Company's common shares being less than US$1.00 per share for the 30 consecutive business days from July 5, 2024 to August 15, 2024. The Notification Letter is only a notification of deficiency, it is not a notice of imminent delisting, and it has no current immediate effect on the listing or trading of the Company's common shares on Nasdaq. About ImmunoPrecise Antibodies Ltd. The IPA Family (as defined below) is a biotherapeutic research and technology group that leverages systems biology, multi-omics modelling and complex artificial intelligence systems to support its proprietary technologies in bioplatform-based antibody discovery.
Show less
Read more
Impact Snapshot
Event Time:
IPA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPA alerts
High impacting ImmunoPrecise Antibodies Ltd. news events
Weekly update
A roundup of the hottest topics
IPA
News
- $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer TherapiesBusiness Wire
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation [Yahoo! Finance]Yahoo! Finance
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationBusiness Wire
- ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyBusiness Wire
- ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024Business Wire
IPA
Earnings
- 9/16/24 - Miss
IPA
Analyst Actions
- 9/17/24 - HC Wainwright
IPA
Sec Filings
- 11/18/24 - Form 6-K
- 11/13/24 - Form 6-K
- 11/4/24 - Form 6-K
- IPA's page on the SEC website